DDR1 antibodies and uses thereof
US12331130B2 · kind B2 · utility
0Cited by
8References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 28, 2023 |
| Grant date | Jun 17, 2025 |
| Priority date | — |
| Expiry date | Feb 28, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to antibodies binding to tumor discoidin domain receptor 1 (DDR1) and the uses of the antibodies in detecting and treating cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.